Cargando…

Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice

A worrisome trend in the study and treatment of infectious disease noted in recent years is the increase in multidrug resistant strains of bacteria concurrent with a scarcity of new antimicrobial agents to counteract this rise. This is particularly true amongst bacteria within the Enterococcus faeci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hebert, Wesley, DiGiandomenico, Antonio, Zegans, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712430/ https://www.ncbi.nlm.nih.gov/pubmed/33147726 http://dx.doi.org/10.3390/vaccines8040638

Ejemplares similares

Environmentally Endemic Pseudomonas aeruginosa Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers
por: Hammond, John H., et al.
Publicado: (2016)

A Pseudomonas aeruginosa-Derived Particulate Vaccine Protects against P. aeruginosa Infection
por: Gonzaga, Zennia Jean C., et al.
Publicado: (2021)

Antivirulence Bispecific Monoclonal Antibody-Mediated Protection against Pseudomonas aeruginosa Ventilator-Associated Pneumonia in a Rabbit Model
por: Aguiar-Alves, Fábio, et al.
Publicado: (2022)

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis
por: Romanowski, Eric G., et al.
Publicado: (2023)

Anti-Psl Targeting of Pseudomonas aeruginosa Biofilms for Neutrophil-Mediated Disruption
por: Ray, Valerie A., et al.
Publicado: (2017)

Publisher Correction: Anti-Psl Targeting of Pseudomonas aeruginosa Biofilms for Neutrophil-Mediated Disruption
por: Ray, Valerie A., et al.
Publicado: (2018)

Serrated Margins in Pseudomonas aeruginosa Keratitis
por: Ishikawa, Eri, et al.
Publicado: (2013)

Recalcitrant Pseudomonas Aeruginosa Keratitis with Hyphaema
por: Chan, Amy, et al.
Publicado: (2021)

Efficacy of a Pseudomonas aeruginosa Serogroup O9 Vaccine
por: Moustafa, Dina A., et al.
Publicado: (2023)

Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice
por: Shaikh, Mohammad Omar Faruk, et al.
Publicado: (2022)

Proteomic analysis of keratitis-associated Pseudomonas aeruginosa
por: Sewell, Abby, et al.
Publicado: (2014)

Monoclonal antibodies against lipopolysaccharide protect against Pseudomonas aeruginosa challenge in mice
por: Kang, Jason, et al.
Publicado: (2023)

Pseudomonas aeruginosa keratitis: passive immunotherapy with antibodies raised against divalent flagellin
por: Mahin Samadi, Pariya, et al.
Publicado: (2019)

Rise in frequency of lasR mutant Pseudomonas aeruginosa among keratitis isolates between 1993 and 2021
por: Shanks, Robert M. Q., et al.
Publicado: (2023)

Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
por: Fukuda, Ken, et al.
Publicado: (2012)

Decreasing HMGB1 levels improves outcome of Pseudomonas aeruginosa keratitis in mice
por: Hazlett, Linda D., et al.
Publicado: (2016)

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening
por: DiGiandomenico, Antonio, et al.
Publicado: (2012)

An unusual case of Acanthamoeba Polyphaga and Pseudomonas Aeruginosa keratitis
por: Hong, Jiaxu, et al.
Publicado: (2014)

A rise in the frequency of lasR mutant Pseudomonas aeruginosa among keratitis isolates between 1993 and 2021
por: Shanks, Robert M. Q., et al.
Publicado: (2023)

Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient
por: Rao, Jayasimha, et al.
Publicado: (2011)

Pseudomonas aeruginosa keratitis misdiagnosed as fungal keratitis by in vivo confocal microscopy: a case report
por: Hong, Jiaxu, et al.
Publicado: (2014)

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
por: Horspool, Alexander M., et al.
Publicado: (2023)

Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis
por: Kugadas, Abirami, et al.
Publicado: (2016)

Pseudomonas aeruginosa Keratitis: Protease IV and PASP as Corneal Virulence Mediators
por: O’Callaghan, Richard, et al.
Publicado: (2019)

Activation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa
por: Osthoff, Michael, et al.
Publicado: (2014)

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
por: Chastre, Jean, et al.
Publicado: (2022)

Lithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis
por: Chen, Kang, et al.
Publicado: (2013)

Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis
por: Ekanayaka, Sandamali A., et al.
Publicado: (2016)

Bilateral Pseudomonas aeruginosa keratitis as presenting feature in an infant of cystic fibrosis
por: Lakshmipathy, Meena, et al.
Publicado: (2022)

Norepinephrine as the Intrinsic Contributor to Contact Lens–Induced Pseudomonas aeruginosa Keratitis
por: Zhang, Bi Ning, et al.
Publicado: (2023)

The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
por: Morris, Amanda J., et al.
Publicado: (2021)

Chlorin e6 mediated photodynamic inactivation for multidrug resistant Pseudomonas aeruginosa keratitis in mice in vivo
por: Wu, Ming-Feng, et al.
Publicado: (2017)

Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models
por: Le, Hoan N., et al.
Publicado: (2019)

MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia Model
por: Le, Hoan N., et al.
Publicado: (2018)

Antibiotic Resistance Characteristics of Pseudomonas aeruginosa Isolated from Keratitis in Australia and India
por: Khan, Mahjabeen, et al.
Publicado: (2020)

Severe Keratitis Caused by Pseudomonas aeruginosa Successfully Treated with Ceftazidime Associated with Acetazolamide
por: Hue, Benoit, et al.
Publicado: (2009)

Stimulator of Interferon Genes Promotes Host Resistance Against Pseudomonas aeruginosa Keratitis
por: Chen, Kang, et al.
Publicado: (2018)

The role of Type III secretion system in the pathogenesis of Pseudomonas aeruginosa microbial keratitis
por: Yang, Justin J., et al.
Publicado: (2021)

An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model
por: Patel, Ami, et al.
Publicado: (2017)

Inhibition of Macrophage Migration Inhibitory Factor Ameliorates Ocular Pseudomonas aeruginosa-Induced Keratitis
por: Gadjeva, Mihaela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dee8pcqtrrgsnr4n42mmni76ms